182 related articles for article (PubMed ID: 16012722)
1. Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer.
Nio Y; Hashimoto K; Yano S; Itakura M; Koike M; Yamaguchi K; Endo S; Tsuji M; Higami T; Maruyama R
Oncol Rep; 2005 Aug; 14(2):401-8. PubMed ID: 16012722
[TBL] [Abstract][Full Text] [Related]
2. Placement of an expandable metallic stent improves the efficacy of chemoradiotherapy for pancreatic cancer with malignant portal vein stenosis or obstruction.
Nio Y; Iguchi C; Itakura M; Nishi T; Hashimoto K; Takeda H; Takamura M; Omori H; Sato Y; Koike M; Endo S
Anticancer Res; 2009 Aug; 29(8):3329-35. PubMed ID: 19661352
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas.
Feliu J; Mel R; Borrega P; López Gómez L; Escudero P; Dorta J; Castro J; Vázquez-Estévez SE; Bolaños M; Espinosa E; González Barón M;
Ann Oncol; 2002 Nov; 13(11):1756-62. PubMed ID: 12419748
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of gemcitabine combined with uracil-tegafur in metastatic pancreatic cancer.
Lee J; Park JO; Kim WS; Lee SI; Song SY; Lim DH; Choi SH; Heo JS; Lee KT; Lee JK; Kim K; Jung CW; Im YH; Lee MH; Kang WK; Park K
Oncology; 2004; 66(1):32-7. PubMed ID: 15031596
[TBL] [Abstract][Full Text] [Related]
5. [Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer].
Nakamori S; Endo W; Ozato H; Shibata T; Takeda Y; Tohno K; Hasuike Y; Masutani S; Morimoto T; Doki Y; Mori M; Monden M
Gan To Kagaku Ryoho; 2011 May; 38(5):789-92. PubMed ID: 21566438
[TBL] [Abstract][Full Text] [Related]
6. [Retrospective analysis of uracil/tegafur, cyclophosphamide and gemcitabine compared with gemcitabine monotherapy in unresectable pancreatic cancer].
Niki T; Yamamoto Y; Tsuda M; Horita K; Hirohata S; Nishisaki H
Gan To Kagaku Ryoho; 2009 Feb; 36(2):273-8. PubMed ID: 19223744
[TBL] [Abstract][Full Text] [Related]
7. [Phase I study of gemcitabine (GEM) and UFT combination chemotherapy for unresectable/recurrent pancreatic cancer].
Nakamori S; Tujie M; Takahashi Y; Maruhashi S; Miyamoto A; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Gan To Kagaku Ryoho; 2004 Jan; 31(1):51-4. PubMed ID: 14750321
[TBL] [Abstract][Full Text] [Related]
8. S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer.
Ke QH; Zhou SQ; Yang JY; Du W; Liang G; Lei Y; Luo F
World J Gastroenterol; 2014 Oct; 20(38):13987-92. PubMed ID: 25320537
[TBL] [Abstract][Full Text] [Related]
9. [Phase I/II study of combination chemotherapy with gemcitabine and UFT for advanced pancreatic cancer in a multi-center trial].
Sumii T; Funakoshi A; Mizumoto K; Tanaka M; Arita Y; Ito T; Yamaguchi H; Ueki T; Sakai T; Miyahara T; Muranaka T; Igarashi H; Shinozaki H; Eriguchi N
Gan To Kagaku Ryoho; 2008 Apr; 35(4):603-6. PubMed ID: 18408428
[TBL] [Abstract][Full Text] [Related]
10. A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer.
Yoshitomi H; Togawa A; Kimura F; Ito H; Shimizu H; Yoshidome H; Otsuka M; Kato A; Nozawa S; Furukawa K; Miyazaki M;
Cancer; 2008 Nov; 113(9):2448-56. PubMed ID: 18823024
[TBL] [Abstract][Full Text] [Related]
11. A Multicenter Phase II Study of Gemcitabine plus S-1 Chemotherapy for Advanced Biliary Tract Cancer.
Arima S; Shimizu K; Okamoto T; Toki M; Suzuki Y; Okano N; Naruge D; Kawai K; Kobayashi T; Kasuga A; Kitamura H; Takasu A; Nagashima F; Sugiyama M; Furuse J
Anticancer Res; 2017 Feb; 37(2):909-914. PubMed ID: 28179351
[TBL] [Abstract][Full Text] [Related]
12. A phase I study of oral uracil-tegafur prior to weekly intravenous gemcitabine in patients with advanced pancreatic cancer.
Tanno S; Nakano Y; Osanai M; Koizumi K; Izawa T; Habiro A; Mizukami Y; Yanagawa N; Fujii T; Okumura T; Kohgo Y
Chemotherapy; 2006; 52(2):98-102. PubMed ID: 16567941
[TBL] [Abstract][Full Text] [Related]
13. miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial.
Khan K; Cunningham D; Peckitt C; Barton S; Tait D; Hawkins M; Watkins D; Starling N; Rao S; Begum R; Thomas J; Oates J; Guzzardo V; Fassan M; Braconi C; Chau I
Oncotarget; 2016 Mar; 7(11):12672-81. PubMed ID: 26862857
[TBL] [Abstract][Full Text] [Related]
14. [Gemcitabine in combination with S-1 or UFT in patients with advanced pancreatic cancer].
Sasajima J; Tanno S; Koizumi K; Nakano Y; Habiro A; Chiba A; Fujii T; Sugiyama Y; Nakamura K; Nishikawa T; Mizukami Y; Okumura T; Kohgo Y
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1657-61. PubMed ID: 19838023
[TBL] [Abstract][Full Text] [Related]
15. A phase I/II study of combination chemotherapy with gemcitabine and 5-fluorouracil for advanced pancreatic cancer.
Okusaka T; Ishii H; Funakoshi A; Ueno H; Furuse J; Sumii T
Jpn J Clin Oncol; 2006 Sep; 36(9):557-63. PubMed ID: 16870696
[TBL] [Abstract][Full Text] [Related]
16. [Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].
Watanabe O; Shimizu T; Imamura H; Kinoshita J; Okabe T; Ogawa K; Haga S
Gan To Kagaku Ryoho; 2004 May; 31(5):717-21. PubMed ID: 15170979
[TBL] [Abstract][Full Text] [Related]
17. [A case of advanced pancreatic cancer treated with chemoradiation].
Nakagawa S; Niinobu T; Itani Y; Nishikawa Y; Amano M; Higaki N; Hayashida H; Sakon M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1859-62. PubMed ID: 16315963
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.
Pazdur R; Lassere Y; Rhodes V; Ajani JA; Sugarman SM; Patt YZ; Jones DV; Markowitz AB; Abbruzzese JL; Bready B
J Clin Oncol; 1994 Nov; 12(11):2296-300. PubMed ID: 7964943
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
Gong JF; Zhang XD; Li J; Di LJ; Jin ML; Shen L
Ai Zheng; 2007 Aug; 26(8):890-4. PubMed ID: 17697554
[TBL] [Abstract][Full Text] [Related]
20. [A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease].
Sunagozaka H; Yamashita T; Kagaya T; Kato Y; Kaneko S
Gan To Kagaku Ryoho; 2006 Jun; 33(6):829-32. PubMed ID: 16770107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
